People who have pro-inflammatory diets are up to three times more likely to have moderate-to-severe IBD, according to a new ...

Meta Platforms META is the IBD Stock Of The Day for Tuesday. Meta stock is ascending from its 21-day moving average ahead of ...

Inflammatory bowel disease (IBD) and autoimmune liver disease (AILD) prevalence are significantly correlated, according to a study in the Journal of Gastroenterology and Hepatology. The findings are ...

Patients with inflammatory bowel disease had a higher risk for venous thromboembolism after surgery for colorectal cancer ...

Among patients with IBD, HLA-B27 positivity and higher UC disease activity were associated with an increased risk for SpA.

Chip leader Nova stock is breaking out past its latest buy point following a string of big gains in heavy volume.

Pumpkin spice benefits go beyond flavor. Learn how cinnamon, nutmeg, ginger, cloves, and allspice support digestion, immunity ...

Although the treatment landscape for inflammatory bowel disease has evolved substantially in recent decades, the ...

SPY072 is a potential first- and best-in-class anti-TL1A antibody for rheumatic diseases targeting quarterly or twice-yearly subcutaneous dosing SKYWAY study is evaluating SPY072 in patients with ...

AbbVie ABBV has gained 22.5% so far this year against a decrease of 0.1% for the industry. The stock has also outperformed ...

Subcutaneous infliximab (Remicade) proved safe and effective for active perianal Crohn's disease in a large multicenter ...

Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, dose optimization and rational therapeutic ...